Trial updateRetina
Study of Zifibancimig in Participants With Neovascular Age-related Macular Degeneration
Completed. Phase 1 / Phase 2. Registered enrolment: 177. Hoffmann-La Roche
Why it matters
Track this study through NCT04567303. No results are posted in this registry record.
The study at a glance
- Registry status
- Completed
- Phase
- Phase 1 / Phase 2
- Registered enrolment
- 177
- Results posted
- No
- Sponsor
- Hoffmann-La Roche
Keep in mind
Registry information describes the study; recruitment status alone does not establish efficacy or safety.
References (1)
Source date: 14 Sept 2026 · United States · Puerto Rico